Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History VERA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics VERA

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield 0.25 %
Consecutive Years 0
Forward Annual Dividend 0.060 USD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 10.01.1996

Vera Therapeutics Inc

VERA
Current price
23.56 USD +0.11 USD (+0.47%)
Last closed 23.20 USD
Company veratx.com
ISIN US92337R1014
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 552 901 760 USD
Yield for 12 month -33.05 %
1Y
3Y
5Y
10Y
15Y
VERA
21.11.2021 - 28.11.2021

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases. The company's lead product candidate consists of atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN). It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California. Address: 2000 Sierra Point Parkway, Brisbane, CA, United States, 94005

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

63.36 USD

P/E Ratio

Dividend Yield

Financials VERA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures VERA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

+1 862 000 USD

Current Quarter

Last Quarter

Current Year

Last Year

+1 862 000 USD

Current Quarter

Last Quarter

EBITDA -193 072 992 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -23.46 %
PEG Ratio
Return On Equity TTM -39.49 %
Wall Street Target Price 63.36 USD
Revenue TTM
Book Value 8.39 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.00 USD
Diluted Eps TTM -3.00 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation VERA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.60
Price Book MRQ 2.89

Technical Indicators VERA

For 52 Weeks

18.53 USD 51.61 USD
50 Day MA 22.88 USD
Shares Short Prior Month 9 560 166
200 Day MA 33.17 USD
Short Ratio 3.76
Shares Short 8 816 548
Short Percent 17.28 %